The UK's biotech sector could help the country avoid a double-dip recession, an expert has suggested.
The UK's biotech sector could help the country avoid a double-dip recession, an expert has suggested.
Michael Baxter, co-author of Bubbles and Wisdom, claimed that this contradicts the common belief that Britain no longer has a manufacturing industry.
"When it comes to biotech, we are a significant player - including the manufacturing - in that sector," he said.
He added that the country is making a number of interesting developments that could contribute to the advancement of the field.
"The UK could possibly hone in on that and could actually do very well as a result of that," he stated.
Mr Baxter highlighted the fact that Britain frequently underrates this area and suggested that it has more opportunities than many investors have identified.
Earlier this month, the BioIndustry Association welcomed the government report of the overview of the UK Bioscience and Health Technology database, which will collate industry statistics in order to inform policy.
$2bn tech-focused hedge fund SoMa Equity Partners to shutter
San Francisco-based hedge fund SoMa Equity Partners is winding down after returning capital to investors, bringing the curtain down on a…
More
Arcana hires former Goldman Sachs exec to Lead EMEA expansion
Portfolio intelligence provider Arcana has appointed former Goldman Sachs executive Rhys Williams as head of EMEA, as the technology firm…
More
ExodusPoint adds Pictet trader to London equities team
Multi-strategy hedge fund major ExodusPoint Capital Management has strengthened its London equities operation with the appointment of Jade…
More